FluxMPS™ MCDB 151 Medium w/o Sodium Bicarbonate: 1X Liquid
FluxMPS™ DCP-M151H-B1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) MCDB 151 −Bicarbonate +HEPES formulation engineered for serum-free or low-protein culture of Human Epidermal Keratinocytes and related cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. The train reaches a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used for conventional filtration — so trace element salts are delivered fully dissolved rather than as particulate aggregates. Formulation: [+] L-Glutamine, [+] Phenol Red, [+] HEPES (28 mM), [+] Calcium, [+] Magnesium, [+] Glucose (1.081 g/L), [+] Sodium Pyruvate | [-] Sodium Bicarbonate.
- Trace element formulation — zinc, copper and iron for metalloenzyme support and antioxidant activity in serum-free culture
- Optimized for Human Epidermal Keratinocytes and CHO cells in CO2-independent culture systems
- 28 mM HEPES (pKa 7.3 at 37°C) — pH-stable without CO2 for open-top chips and atmospheric platforms
- Quadruple-stage filtration (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final cut-off — 5.5× finer than 0.22 µm conventional filtration by pore size
- Endotoxin release specification < 0.05 EU/mL (LAL, USP <85>), tested per manufacturing batch
- Formulated without sodium bicarbonate; buffering provided entirely by HEPES
- Manufactured under an ISO 13485:2016 quality management system; final QC at Diagnocine, Totowa, NJ
- Custom pH, glucose, trace element and growth-factor co-formulations available on request
- Cell typesHuman Epidermal Keratinocytes
- Glucose1081 mg/L (1.081 g/L)
- HEPES28 mM, pKa 7.3 at 37°C
- Sodium Pyruvate55 mg/L
- pH (USP <791>)7.4
- Osmolality (USP <785>)290–330 mOsm/kg H2O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
Engineered where standard media fails
MCDB media formulated with trace element salts can form subvisible particulate aggregates when filtered at 0.22 µm under typical manufacturing conditions. These aggregates clog microfluidic channels, disrupt trace metal bioavailability, and add particulate background to imaging and biosensor readouts. FluxMPS™ addresses these failure modes with four-stage sub-0.04 µm filtration and a < 0.05 EU/mL endotoxin release specification.
Microchannel-safe purity
0.04 µm final filtration keeps trace metal salts fully dissolved — no aggregate deposition in chip channels or culture vessels, and compliance with USP <788> particulate limits.
Total metabolic control
A defined glucose, sodium pyruvate and HEPES composition — without added sodium bicarbonate — supports controlled, CO2-independent culture conditions for keratinocyte and CHO cell studies.
Ultrapure-grade water
Ultrapure Type 1 water (18.2 MΩ·cm) reduces trace-metal and organic-carbon background that would otherwise compete with zinc, copper and iron uptake by low-serum primary cells.
Low background for imaging
Ultra-low particulate filtration reduces debris background for confocal microscopy and biosensor-based readouts in chip-based assays. This formulation contains phenol red for visual pH monitoring.
Rich, stable nutrient profile
20 amino acids, 10 vitamins, and a defined trace element matrix (zinc, copper, iron) — released per micro-batch with full Certificate of Analysis traceability.
Customization on demand
pH, glucose, trace element concentrations, HEPES, and growth factor co-formulations available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages — a repeated pre-filter + final-filter pair run twice — reach a final 0.04 µm polish, delivering particle-free trace element delivery unavailable from conventional 0.22 µm filtered MCDB media.
-
1
0.1 µm Prefiltration I
Removes large aggregates including trace metal salt precipitates; protects the first 0.04 µm cartridge from fouling.
-
2
0.04 µm Final Filtration I — Mycoplasma Barrier
Retains mycoplasma-sized organisms (0.2–0.3 µm) and residual fine particulates absent from standard 0.22 µm filtration.
-
3
0.1 µm Prefiltration II
A second, dedicated prefilter protecting the second 0.04 µm cartridge — redundant protection, not a re-filtration of the first pass.
-
4
0.04 µm Final Filtration II — Polish
Ultimate polishing filter prior to aseptic fill & finish.
Filtration architecture vs. conventional media
A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration of MCDB 151 media.
© Diagnocine® — DCP-M151H-B1X
Specialized cell models & OoC applications
FluxMPS™ DCP-M151H-B1X was formulated for Human Epidermal Keratinocytes and CHO cells in low-protein or serum-free, CO2-independent conditions. The 0.04 µm filtered trace element matrix supports safe use in microfluidic chip architectures where conventional MCDB media can cause trace metal particulate fouling.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra-filtered variant of this MCDB 151 formulation — the separate MPS Grade line described above — is available for automated bioreactor perfusion where trace metal salt nanoparticulates can cause valve fouling.
- Trace Metal Nanoparticulate Removal: 10 nm filtration targets sub-0.04 µm metal salt colloids not addressed by standard QC
- Valve & Sensor Protection: Reduces micro-fouling risk from trace element aggregates in automated systems
- Extended Perfusion Stability: Supports consistent trace element delivery over weeks-long primary cell culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.
Organ-on-a-Chip & MPS
Ultra-clean 0.04 µm filtration reduces the risk of microchannel clogging. Trace elements are delivered particle-free — no aggregate deposition in chip channels.
Skin-on-Chip
FluxMPS™ MCDB 151 −Bicarbonate +HEPES supports sub-mycoplasma-filtration purity and trace element fidelity for skin-on-chip models cultured under low-protein or serum-free conditions.
Keratinocyte OoC
HEPES-buffered, bicarbonate-free formulation supports stable pH during static and perfused keratinocyte chip culture without CO2 supplementation.
CO2-Independent CHO Culture
Bicarbonate-free HEPES buffering enables CHO cell culture in open or CO2-limited systems, including certain robotic and automated culture platforms.
Open-Top Epidermal Chips
Stable HEPES buffering supports extended, gas-exchange-limited incubation typical of open-top epidermal and transwell barrier chip designs.
Imaging & Biosensors
Low particulate background supports confocal microscopy and biosensor-based readouts in chip-based assays. Phenol red is present in this formulation for visual pH monitoring.
Analytical release specifications
Every lot released against the full specification matrix. Available sizes: 500 mL, 1000 mL. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] L-Glutamine, [+] Phenol Red, [+] HEPES (28 mM), [+] Calcium, [+] Magnesium, [+] Glucose (1.081 g/L), [+] Sodium Pyruvate | [-] Sodium Bicarbonate |
| Appearance | Red-colored, clear solution (phenol red present) |
| Glucose | 1081 mg/L (1.081 g/L) |
| HEPES | 28 mM (pKa 7.3 at 37°C) |
| Sodium Pyruvate | 55 mg/L |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 290–330 mOsm/kg H2O |
| Total ingredients | 47 components across 4 categories |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification; see Manufacturing & Compliance) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protect from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | CO2-independent — 28 mM HEPES maintains pH without gas supplementation |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
MCDB 151 −Bicarbonate +HEPES: 47 ingredients verified per lot with CAS numbers for raw-material traceability. Contains trace elements (zinc, copper, iron) for metalloenzyme support and antioxidant activity. HEPES (28 mM, 6600 mg/L) is listed under OTHERS.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 4.411 |
| Cupric sulfate pentahydrate | 7758-99-8 | 0.0025 |
| Disodium hydrogen phosphate anhydrous | 7558-79-4 | 284.080 |
| Ferrous sulfate heptahydrate | 7782-63-0 | 0.417 |
| Magnesium chloride hexahydrate | 7791-18-6 | 122.000 |
| Potassium chloride | 7447-40-7 | 111.830 |
| Sodium acetate anhydrous | 127-09-3 | 301.530 |
| Sodium chloride | 7647-14-5 | 7599.000 |
| Zinc sulfate heptahydrate | 7446-20-0 | 0.863 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 7.510 |
| L-Alanine | 56-41-7 | 8.910 |
| L-Arginine hydrochloride | 1119-34-2 | 210.700 |
| L-Asparagine monohydrate | 5794-13-8 | 15.000 |
| L-Aspartic acid | 56-84-8 | 3.990 |
| L-Cysteine hydrochloride monohydrate | 7048-04-6 | 42.040 |
| L-Glutamic acid | 56-86-0 | 14.710 |
| L-Glutamine | 56-85-9 | 877.200 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 16.770 |
| L-Isoleucine | 73-32-5 | 1.968 |
| L-Leucine | 61-90-5 | 65.600 |
| L-Lysine hydrochloride | 657-27-2 | 18.270 |
| L-Methionine | 63-68-3 | 4.476 |
| L-Phenylalanine | 63-91-2 | 4.956 |
| L-Proline | 147-85-3 | 34.530 |
| L-Serine | 56-45-1 | 63.060 |
| L-Threonine | 72-19-5 | 11.910 |
| L-Tryptophan | 73-22-3 | 3.060 |
| L-Tyrosine disodium salt dihydrate | 69847-15-0 | 3.920 |
| L-Valine | 72-18-4 | 35.130 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 13.960 |
| D-Biotin | 58-85-5 | 0.015 |
| D-Ca-Pantothenate | 137-08-6 | 0.238 |
| Folic acid | 59-30-3 | 0.790 |
| Niacinamide | 98-92-0 | 0.037 |
| Pyridoxine hydrochloride | 58-56-0 | 0.061 |
| Riboflavin | 83-88-5 | 0.038 |
| Thiamine hydrochloride | 67-03-8 | 0.337 |
| Vitamin B12 | 68-19-9 | 0.407 |
| myo-Inositol | 87-89-8 | 18.020 |
| OTHERS | ||
| Adenine hydrochloride | 2922-28-1 | 30.880 |
| D-Glucose | 50-99-7 | 1081.000 |
| HEPES | 7365-45-9 | 6600.000 |
| Phenol red sodium salt | 34487-61-1 | 1.242 |
| Putrescine dihydrochloride | 333-93-7 | 0.161 |
| Sodium pyruvate | 113-24-6 | 55.000 |
| Thioctic acid | 1077-28-7 | 0.206 |
| Thymidine | 50-89-5 | 0.727 |
Manufacturing & compliance
Every FluxMPS™ product is manufactured and released under a multi-layer quality system, with particular attention to trace element dissolution and particulate removal during MCDB formulation.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016–certified facilities. Final QA at Diagnocine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm — reduces ionic and organic-carbon background in trace-element MCDB formulations where contaminants can compete with zinc, copper, and iron uptake.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch production, per-lot traceability, Certificate of Analysis for every batch — trace element concentrations verified against specification.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
Endotoxin — USP <85> BET
LAL assay; release specification < 0.05 EU/mL, tested per manufacturing batch.
Particulate — USP <788> Method 1
Light obscuration: NMT 25/mL (≥10 µm), NMT 3/mL (≥25 µm).
Osmolality — USP <785>
Target: 290–330 mOsm/kg H2O.
Documentation & CoA
Full CoA with raw-material traceability available for every batch on request.
How DCP-M151H-B1X compares
FluxMPS™ DCP-M151H-B1X vs. conventional 0.22 µm–filtered MCDB 151 −Bicarbonate +HEPES formulations.
| Parameter | DCP-M151H-B1X (FluxMPS™) | Conventional MCDB 151 −Bicarbonate +HEPES (0.22 µm filtered) |
Standard Alt. MCDB (0.22 µm filtered) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| MCDB 151 without sodium bicarbonate + HEPES — CO2-independent keratinocyte/CHO culture | check_circle Yes | cancel No | cancel No |
| Trace element delivery | Particle-free (0.04 µm) | May contain aggregates | May contain aggregates |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle Yes (0.1 µm) | cancel No | cancel No |
| Endotoxin (release specification) | FluxMPS™ — < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate tested | check_circle Yes (Method 1) | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Not specified | Not specified |
| Manufacturing QMS | ISO 13485:2016 | Not specified | Not specified |
| Microfluidic channel compatibility | check_circle Microfluidics Suitable | cancel Risk of clogging | cancel Risk of clogging |
| Custom formulation | check_circle Available | cancel Fixed | cancel Fixed |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-M151H-B1X MCDB 151 −Bicarbonate +HEPES.
Supporting literature
Key publications supporting MCDB 151 −Bicarbonate +HEPES for Human Epidermal Keratinocytes culture and organ-on-a-chip applications.
- Ham RG, McKeehan WL. Media and growth requirements. Methods Enzymol. 1979;58:44–93. doi:10.1016/S0076-6879(79)58127-6
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
- Boyce ST, Ham RG. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol. 1983;81(1 Suppl):33s–40s. doi:10.1111/1523-1747.ep12540422
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
- Sung JH, et al. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j

